Product labeling includes a fetal indication for use that is not cleared under its 510(k).
Source facts
Action
On March 4, 2026, firm began notifying customers via first-class mail. Customers were informed they may still use the BiDop 3 device for vascular applications, but that the device is not cleared for fetal usage.
Koven Technology, Inc. will provide a replacement operation manual for devices that are being amended to remove fetal use indications.
Initiated
2026-03-04
Root cause
Labeling Change Control
Distribution
US Nationwide distribution in the states of LA, NC, MT, TX MA, OR, NY, IL, CO, GA, FL, WA, WI, MO, AZ, IN.
Recall number
Z-1631-2026
Recall status
Open, Classified
CDRH record ID
219078
FDA classified
2026-03-24
Recall event number
98556
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.